Article Details

Study shows anti-inflammatory drug reduces risk of death in hospitalized COVID-19 patients

Retrieved on: 2021-02-11 18:41:44

Tags for this article:

Click the tags to see associated articles and topics

Study shows anti-inflammatory drug reduces risk of death in hospitalized COVID-19 patients. View article details on hiswai:

Excerpt

The Food and Drug Administration (FDA) has approved remdesivir as a treatment for hospitalized COVID-19 patients at least 12 years old, because it ...

Article found on: thehill.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo